Effectiveness of AV-stimulation in Immersive VR to Improve Visual Perception and Driving Performance
Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Jan 25, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special virtual reality (VR) training program can help improve visual perception and driving skills in people who have had a stroke or have other visual and cognitive challenges that affect their ability to drive. Over six weeks, participants will take part in VR sessions every two days to see if this training makes it easier for them to notice things visually and perform better when driving. Some participants will start the training right away, while others will wait six weeks before beginning.
To join the study, you need to be over 25 years old, have some vision problems due to a stroke or brain injury, and have previously held a valid driver’s license. You should also be able to follow instructions and have access to Wi-Fi at home. Throughout the study, participants will take tests to measure their driving performance and visual skills at the start, middle, and end. This trial is important because it aims to find new ways to help people regain their confidence and ability to drive safely after experiencing visual impairments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female \> 25 years old.
- • Visual field defects due to TBI or stroke
- • BCVA ≥ 20/50.
- • Previously held a valid driving license and were active drivers.
- • Ability to follow the visual and auditory stimuli and training instructions.
- • Online auditory test positive (-5dBHL to 60dBHL range) at 125 Hz (for research purposes only)
- • Home Wi-Fi access.
- Exclusion Criteria:
- • Both eyes with media opacity that impairs visual field testing.
- • Inability to perform during testing and training.
- • Cognitive/motor condition incompatible with driving simulator and/or VR.
- • Recreational or medicinal consumption of psychoactive drugs.
- • 3 consecutive VRISE scores \< 25 at inclusion.
- • History of vertigo or dizziness.
- • Visual neglect.
- • Prior/current vision rehabilitation interventions.
- • Photosensitive epilepsy.
About University Health Network, Toronto
University Health Network (UHN), based in Toronto, is a leading academic health sciences center dedicated to advancing patient care through innovative research and education. As a prominent sponsor of clinical trials, UHN integrates cutting-edge scientific discoveries with clinical practice, facilitating the development of new therapies and treatment modalities. With a commitment to improving health outcomes, UHN collaborates with a diverse network of researchers, healthcare professionals, and industry partners, fostering an environment that prioritizes patient safety and ethical standards in clinical research. Through its extensive resources and expertise, UHN plays a pivotal role in transforming healthcare and enhancing the quality of life for patients both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Toronto, Ontario, Canada
Patients applied
Trial Officials
Michael Reber, PhD
Principal Investigator
University Health Network, Toronto
Lora Appel, PhD
Principal Investigator
York University
Jennifer Campos, PhD
Principal Investigator
University Health Network, Toronto
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials